Cellosaurus JAR (CVCL_0360)

Cell line name JAR
Synonyms Jar; JAr; JaR
Accession CVCL_0360
Resource Identification Initiative To cite this cell line use: JAR (RRID:CVCL_0360)
Comments Doubling time: ~20-30 hours (DSMZ).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Disease Gestational choriocarcinoma (NCIt: C4646)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Category Cancer cell line
STR profile Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; KCLB

Markers:
AmelogeninX,Y
CSF1PO7,10
D13S31711
D16S5399,10
D18S5113,17
D21S1130
D3S135814 (CLS)
16,17 (KCLB)
D5S81810,11
D7S82010,11
D8S117914,16
FGA22
Penta D9,11
Penta E10,12
TH016,7
TPOX8,11
vWA16,18
Publications

DOI=10.1007/BF02619074
Pattillo R.A., Ruckert A.C.F., Hussa R.O., Bernstein R., Delfs E.
The JAr cell line -- continuous human multihormone production and controls.
In Vitro 6:398-399(1971)

PubMed=7153601
Sasaki S., Katayama P.K., Roesler M., Pattillo R.A., Mattingly R.F., Ohkawa K.
Cytogenetic analysis of choriocarcinoma cell lines.
Nippon Sanka Fujinka Gakkai Zasshi 34:2253-2256(1982)

PubMed=4038916; DOI=10.1016/0165-4608(85)90052-4
Sheppard D.M., Fisher R.A., Lawler S.D.
Karyotypic analysis and chromosome polymorphisms in four choriocarcinoma cell lines.
Cancer Genet. Cytogenet. 16:251-258(1985)

PubMed=3518877; DOI=10.3109/07357908609038260
Fogh J.
Human tumor lines for cancer research.
Cancer Invest. 4:157-184(1986)

PubMed=2720636; DOI=10.1016/0165-4608(89)90664-X
Surti U., Habibian R.
Chromosomal rearrangement in choriocarcinoma cell lines.
Cancer Genet. Cytogenet. 38:229-240(1989)

PubMed=7937597; DOI=10.1016/0143-4004(94)90008-6
Grummer R., Hohn H.-P., Mareel M.M., Denker H.-W.
Adhesion and invasion of three human choriocarcinoma cell lines into human endometrium in a three-dimensional organ culture system.
Placenta 15:411-429(1994)

PubMed=7716126; DOI=10.1016/0143-4004(95)90079-9
Mitchell A.M., Yap A.S., Payne E.J., Manley S.W., Mortimer R.H.
Characterization of cell polarity and epithelial junctions in the choriocarcinoma cell line, JAR.
Placenta 16:31-39(1995)

PubMed=24098444; DOI=10.1371/journal.pone.0076205
Vuoristo S., Toivonen S., Weltner J., Mikkola M., Ustinov J., Trokovic R., Palgi J., Lund R., Tuuri T., Otonkoski T.
A novel feeder-free culture system for human pluripotent stem cell culture and induced pluripotent stem cell derivation.
PLoS ONE 8:E76205-E76205(2013)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cross-references
Cell line collections ATCC; HTB-144
BCRC; 60491
CLS; 300221/p449_JAR
DSMZ; ACC-462
IZSLER; BS TCL 182
KCLB; 30144
Cell line databases/resources CCRID; 3131C0001000700028
CCRID; 3131C0001000700156
Cosmic-CLP; 907175
GDSC; 907175
IGRhCellID; JAR
LINCS_LDP; LCL-1491
TOKU-E; 2064
Ontologies BTO; BTO:0001585
CLO; CLO_0007011
EFO; EFO_0002211
MCCL; MCC:0000254
Biological sample resources BioSample; SAMN01821568
BioSample; SAMN01821637
BioSample; SAMN03472717
Chemistry resources ChEMBL-Cells; CHEMBL3307657
ChEMBL-Targets; CHEMBL614587
Gene expression databases GEO; GSM827264
GEO; GSM1669947
Polymorphism and mutation databases Cosmic; 907175
Cosmic; 2077193